title: Acute myelogenous leukemia following mitoxantrone treatment for multiple sclerosis.
authors.forename: Ingrid
authors.initials: I
authors.lastname: Mogenet
authors.forename: Elise
authors.initials: E
authors.lastname: Simiand-Erdociain
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Canonge
authors.forename: Jacques
authors.initials: J
authors.lastname: Pris
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008942:Mitoxantrone / Q000009:adverse effects* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents; D008942:Mitoxantrone